DEAL BRIEF
Morgan Stanley Private Equity Asia, one of the leading private equity investors in Asia-Pacific, has acquired minority stake, for a total consideration of USD 25 million (approximately), in ZCL Chemicals Limited (formerly Zandu Chemicals Ltd.), one of the fastest growing pharmaceutical companies in India, headquartered in Mumbai and engaged in manufacturing, supplying and selling specialty chemicals, advanced drug intermediates and active pharmaceutical ingredients (APIs).
Press coverage relation to this transaction is available at here and here.
OUR ROLE
We, at Nishith Desai Associates, acted as the transaction counsel to Morgan Stanley PE Asia and advised on strategic and legal aspects of the transaction including the negotiations and deal documentation.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
